Determination of Dopamine and Its Metabolites in Mice Striatum by Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry
摘 要
提出了超高效液相色谱-串联质谱法同时测定小鼠纹状体中多巴胺(DA)及其代谢物高原儿茶酸(DOPAC)与高香草酸(HVA)含量的方法。取小鼠纹状体约10 mg,用200 μL 2%(体积分数)甲酸溶液提取、离心。取上清液80 μL,加入40 μg·L-1异丙肾上腺素(内标)溶液10 μL和含0.1%(体积分数,下同)乙酸的甲醇溶液10 μL,涡旋混匀,再加入100 μL甲醇,涡旋、离心。上清液中DA及其代谢物在Gemini NX-C18色谱柱上分离,以不同体积比的0.1%乙酸溶液和含0.1%乙酸的甲醇溶液混合液为流动相进行梯度洗脱,质谱分析采用电喷雾离子源正、负离子模式,选择反应监测(SRM)模式扫描。结果表明,3种目标物在7.00 min内能完成测定。DA、DOPAC和HVA标准曲线的线性范围分别为0.05~100,0.5~1 000,0.25~500 μg·L-1,检出限分别为0.015,0.150,0.075 μg·L-1。按照标准加入法进行回收试验,回收率为84.4%~117%,日内精密度和日间精密度试验所得测定值的相对标准偏差均小于15%。质控样品在自动进样器中保存8 h、4℃保存24 h以及-80℃保存30 d前后3种目标物测定值的相对误差绝对值不大于20%,说明样品稳定性良好。
Abstract
A method was proposed for the simultaneous determination of dopamine (DA) and its metabolites of high protocatechuic acid (DOPAC) and high vanillic acid (HVA) in mice striatum by ultra-high performance liquid chromatography tandem mass spectrometry. About 10 mg of mice striatum was extracted with 200 μL of 2% (volume fraction) formic acid solution and centrifuged. The supernatant (80 μL) was taken and 10 μL of 40 μg·L-1 isoproterenol (internal standard) solution and 10 μL of methanol solution containing 0.1% (volume fraction, the same below) acetic acid were added. After vortex mixing, 100 μL of methanol was added, followed by vortex mixing and centrifugation. The DA and its metabolites in the supernatant were separated on a Gemini NX-C18 column using a mixture of 0.1% acetic acid solution and methanol solution containing 0.1% acetic acid at different volume ratios as the mobile phase for gradient elution. And the mass spectrometry analysis was performed by electrospray ion source with positive and negative ion modes, and scanned by selective reaction monitoring (SRM) mode. As shown by the results, the three targets could be determined within 7.00 min. The linear ranges of the standard curves for DA, DOPAC and HVA were 0.05-100, 0.5-1 000, 0.25-500 μg·L-1, and the detection limits were 0.015, 0.150, 0.075 μg·L-1, respectively. According to the standard addition method, the recoveries of the three targets ranged from 84.4%-117%. RSDs of the determined values of tests for intra-day precision and inter-day precision were less than 15%. The determined values of the relative error for the three targets in quality control samples stored in an autosampler for 8 h, at 4℃ for 24 h and at -80℃ for 30 d were not more than 20%, indicating good sample stability.
中图分类号 O657.63 DOI 10.11973/lhjy-hx202312003
所属栏目 工作简报
基金项目 广东省自然科学基金面上项目(2021A1515010780)
收稿日期 2022/8/11
修改稿日期
网络出版日期
作者单位点击查看
备注梁金良,硕士,主要从事质谱检验工作
引用该论文: LIANG Jinliang,CHEN Xiaotong,HU Kunhua. Determination of Dopamine and Its Metabolites in Mice Striatum by Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry[J]. Physical Testing and Chemical Analysis part B:Chemical Analysis, 2023, 59(12): 1381~1387
梁金良,陈晓彤,胡坤华. 超高效液相色谱-串联质谱法测定小鼠纹状体中多巴胺及其代谢物的含量[J]. 理化检验-化学分册, 2023, 59(12): 1381~1387
共有人对该论文发表了看法,其中:
人认为该论文很差
人认为该论文较差
人认为该论文一般
人认为该论文较好
人认为该论文很好
参考文献
【1】HADDAD F, SAWALHA M, KHAWAJA Y, et al. Dopamine and levodopa prodrugs for the treatment of Parkinson's disease[J]. Molecules, 2017,23(1):40-40.
【2】DE LAU L M L, BRETELER M M B. Epidemiology of Parkinson's disease[J]. The Lancet. Neurology, 2006,5(6):525-535.
【3】NUSSBAUM R L, ELLIS C E. Alzheimer's disease and Parkinson's disease[J]. New England Journal of Medicine, 2003,348(14):1356-1364.
【4】CROSIERS D, THEUNS J, CRAS P, et al. Parkinson disease:Insights in clinical, genetic and pathological features of monogenic disease subtypes[J]. Journal of Chemical Neuroanatomy, 2011,42(2):131-141.
【5】HINDLE J V. Ageing, neurodegeneration and Parkinson's disease[J]. Age and Ageing, 2010,39(2):156-161.
【6】SAMII A, NUTT J G, RANSOM B R. Parkinson's disease[J]. The Lancet, 2004,363(9423):1783-1793.
【7】BENES F M. Carlsson and the discovery of dopamine[J]. Trends in Pharmacological Sciences, 2001,22(1):46-47.
【8】LATIF S, JAHANGEER M, MAKNOON R D, et al. Dopamine in Parkinson's disease[J]. Clinica Chimica Acta, 2021,522:114-126.
【9】KAMAL E F B, FEN Y W. The principle of nanomaterials based surface plasmon resonance biosensors and its potential for dopamine detection[J]. Molecules, 2020,25(12):2769.
【10】KLEIN M O, BATTAGELLO D S, CARDOSO A R, et al. Dopamine:Functions, signaling, and association with neurological diseases[J]. Cellular and Molecular Neurobiology, 2019,39(1):31-59.
【11】FAHN S. The medical treatment of Parkinson disease from James Parkinson to George Cotzias[J]. Movement Disorders:Official Journal of the Movement Disorder Society, 2015,30(1):4-18.
【12】VERHAGEN M L, PAL G, SLAVIN K. Surgical treatment of Parkinson's disease[J]. Current Treatment Options in Neurology, 2016,18(11):49-49.
【13】CAI Y Y, XING L Y, YANG T, et al. The neurodevelopmental role of dopaminergic signaling in neurological disorders[J]. Neuroscience Letters, 2021,741:135540.
【14】MONZANI E, NICOLIS S, DELL'ACQUA S, et al. Dopamine, oxidative stress and protein-quinone modifications in Parkinson's and other neurodegenerative diseases[J]. Angewandte Chemie International Edition, 2019,58(20):6512-6527.
【15】FOLEY P B. Dopamine in psychiatry:A historical perspective[J]. Journal of Neural Transmission, 2019,126(4):473-479.
【16】庄晓利,韩超,张晨,等.基于ZIF-67的Co3O4/C修饰电极制备及对多巴胺传感性能研究[J].分析试验室, 2021,40(3):265-269.
【17】张景瑞,张宇航,杨善厚,等.基于异金属有机骨架材料的Fe2O3/CuO/C制备及多巴胺电化学传感性能研究[J].分析试验室, 2022,41(7):770-775.
【18】吴素仪,张菊梅,卢朝粉,等.氯离子加速的铜基芬顿反应用于对多巴胺的比色检测[J].分析试验室, 2022,41(3):262-266.
【19】WU X M, WANG R, JIANG Q Q, et al. Determination of amino acid neurotransmitters in rat hippocampi by HPLC-UV using NBD-F as a derivative[J]. Biomedical Chromatography:BMC, 2014,28(4):459-462.
【20】GEUNS J M C, ORRIACH M L, SWENNEN R, et al. Simultaneous liquid chromatography determination of polyamines and arylalkyl monoamines[J]. Analytical Biochemistry, 2006,354(1):127-131.
【21】BUCHER E S, WIGHTMAN R M. Electrochemical analysis of neurotransmitters[J]. Annual Review of Analytical Chemistry, 2015,8:239-261.
【22】GONZÁLEZ R R, FERNÁNDEZ R F, VIDAL J L M, et al. Development and validation of an ultra-high performance liquid chromatography-tandem mass-spectrometry (UHPLC-MS/MS) method for the simultaneous determination of neurotransmitters in rat brain samples[J]. Journal of Neuroscience Methods, 2011,198(2):187-194.
【23】KOVAC A, SOMIKOVA Z, ZILKA N, et al. Liquid chromatography-tandem mass spectrometry method for determination of panel of neurotransmitters in cerebrospinal fluid from the rat model for tauopathy[J]. Talanta, 2014,119:284-290.
【24】LAKKAPPA N, KRISHNAMURTHY P T, YAMJALA K, et al. Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster:LC-MS/MS method development[J]. Journal of Pharmaceutical and Biomedical Analysis, 2018,149:457-464.
【25】XU H R, WANG Z R, ZHU L, et al. Targeted neurotransmitters profiling identifies metabolic signatures in rat brain by LC-MS/MS:Application in insomnia, depression and Alzheimer's disease[J]. Molecules, 2018,23(9):2375.
【26】POH E Z, HAHNE D, MORETTI J, et al. Simultaneous quantification of dopamine, serotonin, their metabolites and amino acids by LC-MS/MS in mouse brain following repetitive transcranial magnetic stimulation[J]. Neurochemistry International, 2019,131:104546.
【27】HE B S, BI K S, JIA Y, et al. Rapid analysis of neurotransmitters in rat brain using ultra-fast liquid chromatography and tandem mass spectrometry:Application to a comparative study in normal and insomnic rats[J]. Journal of Mass Spectrometry, 2013,48(8):969-978.
【2】DE LAU L M L, BRETELER M M B. Epidemiology of Parkinson's disease[J]. The Lancet. Neurology, 2006,5(6):525-535.
【3】NUSSBAUM R L, ELLIS C E. Alzheimer's disease and Parkinson's disease[J]. New England Journal of Medicine, 2003,348(14):1356-1364.
【4】CROSIERS D, THEUNS J, CRAS P, et al. Parkinson disease:Insights in clinical, genetic and pathological features of monogenic disease subtypes[J]. Journal of Chemical Neuroanatomy, 2011,42(2):131-141.
【5】HINDLE J V. Ageing, neurodegeneration and Parkinson's disease[J]. Age and Ageing, 2010,39(2):156-161.
【6】SAMII A, NUTT J G, RANSOM B R. Parkinson's disease[J]. The Lancet, 2004,363(9423):1783-1793.
【7】BENES F M. Carlsson and the discovery of dopamine[J]. Trends in Pharmacological Sciences, 2001,22(1):46-47.
【8】LATIF S, JAHANGEER M, MAKNOON R D, et al. Dopamine in Parkinson's disease[J]. Clinica Chimica Acta, 2021,522:114-126.
【9】KAMAL E F B, FEN Y W. The principle of nanomaterials based surface plasmon resonance biosensors and its potential for dopamine detection[J]. Molecules, 2020,25(12):2769.
【10】KLEIN M O, BATTAGELLO D S, CARDOSO A R, et al. Dopamine:Functions, signaling, and association with neurological diseases[J]. Cellular and Molecular Neurobiology, 2019,39(1):31-59.
【11】FAHN S. The medical treatment of Parkinson disease from James Parkinson to George Cotzias[J]. Movement Disorders:Official Journal of the Movement Disorder Society, 2015,30(1):4-18.
【12】VERHAGEN M L, PAL G, SLAVIN K. Surgical treatment of Parkinson's disease[J]. Current Treatment Options in Neurology, 2016,18(11):49-49.
【13】CAI Y Y, XING L Y, YANG T, et al. The neurodevelopmental role of dopaminergic signaling in neurological disorders[J]. Neuroscience Letters, 2021,741:135540.
【14】MONZANI E, NICOLIS S, DELL'ACQUA S, et al. Dopamine, oxidative stress and protein-quinone modifications in Parkinson's and other neurodegenerative diseases[J]. Angewandte Chemie International Edition, 2019,58(20):6512-6527.
【15】FOLEY P B. Dopamine in psychiatry:A historical perspective[J]. Journal of Neural Transmission, 2019,126(4):473-479.
【16】庄晓利,韩超,张晨,等.基于ZIF-67的Co3O4/C修饰电极制备及对多巴胺传感性能研究[J].分析试验室, 2021,40(3):265-269.
【17】张景瑞,张宇航,杨善厚,等.基于异金属有机骨架材料的Fe2O3/CuO/C制备及多巴胺电化学传感性能研究[J].分析试验室, 2022,41(7):770-775.
【18】吴素仪,张菊梅,卢朝粉,等.氯离子加速的铜基芬顿反应用于对多巴胺的比色检测[J].分析试验室, 2022,41(3):262-266.
【19】WU X M, WANG R, JIANG Q Q, et al. Determination of amino acid neurotransmitters in rat hippocampi by HPLC-UV using NBD-F as a derivative[J]. Biomedical Chromatography:BMC, 2014,28(4):459-462.
【20】GEUNS J M C, ORRIACH M L, SWENNEN R, et al. Simultaneous liquid chromatography determination of polyamines and arylalkyl monoamines[J]. Analytical Biochemistry, 2006,354(1):127-131.
【21】BUCHER E S, WIGHTMAN R M. Electrochemical analysis of neurotransmitters[J]. Annual Review of Analytical Chemistry, 2015,8:239-261.
【22】GONZÁLEZ R R, FERNÁNDEZ R F, VIDAL J L M, et al. Development and validation of an ultra-high performance liquid chromatography-tandem mass-spectrometry (UHPLC-MS/MS) method for the simultaneous determination of neurotransmitters in rat brain samples[J]. Journal of Neuroscience Methods, 2011,198(2):187-194.
【23】KOVAC A, SOMIKOVA Z, ZILKA N, et al. Liquid chromatography-tandem mass spectrometry method for determination of panel of neurotransmitters in cerebrospinal fluid from the rat model for tauopathy[J]. Talanta, 2014,119:284-290.
【24】LAKKAPPA N, KRISHNAMURTHY P T, YAMJALA K, et al. Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster:LC-MS/MS method development[J]. Journal of Pharmaceutical and Biomedical Analysis, 2018,149:457-464.
【25】XU H R, WANG Z R, ZHU L, et al. Targeted neurotransmitters profiling identifies metabolic signatures in rat brain by LC-MS/MS:Application in insomnia, depression and Alzheimer's disease[J]. Molecules, 2018,23(9):2375.
【26】POH E Z, HAHNE D, MORETTI J, et al. Simultaneous quantification of dopamine, serotonin, their metabolites and amino acids by LC-MS/MS in mouse brain following repetitive transcranial magnetic stimulation[J]. Neurochemistry International, 2019,131:104546.
【27】HE B S, BI K S, JIA Y, et al. Rapid analysis of neurotransmitters in rat brain using ultra-fast liquid chromatography and tandem mass spectrometry:Application to a comparative study in normal and insomnic rats[J]. Journal of Mass Spectrometry, 2013,48(8):969-978.
相关信息